Connect your AI

AbCellera Biologics Inc. ABCL Earnings yield

Earnings yield at other companies

Twist Bioscience CorporationTWST

-2.8%-1.1pp

Recursion Pharmaceuticals, Inc.RXRX

-34.5%+13.2pp

AnaptysBio, Inc.ANAB

-9.9%-2.8pp

PrecigenPGEN

-14.9%-5.5pp

ZymeworksZYME

-5.5%-2.1pp

ADMA BiologicsADMA

7.7%+3.3pp

Other financials

Income statement

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

Market cap$1.84B+59.2%

Profitability

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Calculated from AbCellera Biologics Inc.’s reported figures.

net income/market cap=-13.6%

Based on trailing twelve months.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AbCellera Biologics Inc.'s earnings yield?: AbCellera Biologics Inc. (ABCL) reported earnings yield of -13.6% in Q1 2026.
How has AbCellera Biologics Inc.'s earnings yield changed year-over-year?: AbCellera Biologics Inc.'s earnings yield increased by 46.1% year-over-year, from -25.3% to -13.6%.
What is the long-term trend for AbCellera Biologics Inc.'s earnings yield?: Over 4 years (2020 to 2025), AbCellera Biologics Inc.'s earnings yield has grown at a 92.1% compound annual growth rate (CAGR), from 1% to -14.3%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.